drugset / Trial / NCT03152123

Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users

NCT03152123

Phase 1 Completed 43 enrolled Bioprojet
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the abuse potential of single doses of pitolisant relative to phentermine HCl and placebo, when administered to healthy, non-dependent, recreational stimulant users.

Timeline

Start
2017-03-15
Primary completion
2017-10-23
Completion
2017-10-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phentermine Small molecule 60 mg
Subject Pitolisant Small molecule 40 mg
Subject Pitolisant Small molecule 240 mg

Indications